Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response
European Journal of Neurology · 2023
DOI: 10.1111/ene.15736 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Journal of Neurology, 2023. Verfasst von Anja Sofie Petersen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Danish Headache Centre, Copenhagen University Hospital, Rigshospitalet-Glostrup, Glostrup, Denmark. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP3A, Cluster Headache. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lundbeckfonden, TrygFonden.
Abstract (Originalsprache)
Background and purpose The response to cluster headache treatments has a high interindividual variation. To date, treatment response has only been assessed by a candidate gene approach and no investigations into metabolic pathways have been performed. Our aim was to investigate the association between the polygenetic risk of cluster headache and treatment response to first‐line cluster headache treatments as well as known functional variants of CYP3A4 and the response to verapamil. Further, it was aimed to replicate previous single nucleotide polymorphisms found to be associated with treatment response in cluster headache and/or migraine.
Methods
In, 508 cluster headache patients diagnosed according to the International Classification of Headache Disorders were genotyped and participated in a semi‐structured interview to evaluate treatment response. Polygenetic risk scores were calculated by the effect retrieved from a meta‐analysis of the latest two genome‐wide association studies on cluster headache.
Results
Inferior treatment response to oxygen, triptans and verapamil is associated with chronicity of cluster headache were confirmed but no evidence was found that a response could be predicted by a high genetic risk of cluster headache. Likewise, verapamil response was not associated with functional variants of CYP3A4 . No support of the genetic variants previously reported to be associated with treatment response to triptans or verapamil was found.
Conclusion
The clinically relevant variation in treatment response for cluster headache was not influenced by genetic factors in the present study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Danish Headache Centre, Copenhagen University Hospital, Rigshospitalet-Glostrup, Glostrup, Denmark.
- Department of Clinical Physiology and Nuclear Medicine, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Division of Clinical Neuroscience, Department of Research and Innovation, Oslo University Hospital, Oslo, Norway.
- Department of Neurology, Oslo University Hospital, Oslo, Norway.
- Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
ORCID-Profile: Anja Sofie Petersen, Nunu Lund, Mona Ameri Chalmer, Bendik Slagsvold Winsvold, Malene Bredahl Hansen
Förderung
- Lundbeckfonden
- TrygFonden
Zitieren
APA
Petersen, A. S., Barloese, M., Lund, N., Pedersen, A. F., Søborg, M. K., Chalmer, M. A., Callesen, I., Winsvold, B. S., Zwart, J. A., DBDS Genomic Consortium, Ostrowski, S. R., Pedersen, O. B., Sellebjerg, F., Søndergaard, H. B., Hansen, M. B., Jensen, R. H., & Hansen, T. F. (2023). Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response. European Journal of Neurology. https://doi.org/10.1111/ene.15736
Vancouver
Petersen AS, Barloese M, Lund N, Pedersen AF, Søborg MK, Chalmer MA, et al. Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response. European Journal of Neurology. 2023. doi:10.1111/ene.15736
BibTeX
@article{Petersen2023,
author = {Petersen, Anja Sofie and Barloese, Mads and Lund, Nunu and Pedersen, Adam Friis and Søborg, Marie-Louise Kulas and Chalmer, Mona Ameri and Callesen, Ida and Winsvold, Bendik Slagsvold and Zwart, John-Anker and DBDS Genomic Consortium, DBDS Genomic Consortium and Ostrowski, Sisse Rye and Pedersen, Ole Birger and Sellebjerg, Finn and Søndergaard, Helle Bach and Hansen, Malene Bredahl and Jensen, Rigmor Højland and Hansen, Thomas Folkmann},
title = {Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response},
journal = {European Journal of Neurology},
year = {2023},
doi = {10.1111/ene.15736}
}
EUVIMED